Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | CES1 | P23141 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7050949 | 1.00 | TSHR (0.59) | TSHRSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL14629580 | 0.89 | TSHR (0.52) | TSHRSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL30620467 | 0.87 | PDPK1 (0.60) | KDM4EMAPTL3MBTL1KMT2AMEN1 | |
| SCHEMBL29110668 | 0.87 | PDPK1 (0.60) | KDM4EMAPTL3MBTL1KMT2AMEN1 | |
| SCHEMBL29110670 | 0.87 | NPC1 (0.58) | TSHRSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL29110671 | 0.87 | MGAM (0.53) | TSHRNPC1RAB9AMAPTL3MBTL1 | |
| SCHEMBL29110669 | 0.87 | KMT2A (0.51) | TSHRNPC1RAB9AALDH1A1LMNA | |
| SCHEMBL29110666 | 0.87 | HSD11B1 (0.49) | TSHRSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL29110675 | 0.87 | KMT2A (0.58) | TSHRNPC1RAB9AALDH1A1MAPT | |
| SCHEMBL29110681 | 0.87 | MGAM (0.53) | TSHRSMN1; SMN2NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108017518-B | 1, 3-diphenyl-1-propanol and preparation method thereof | 湖北远大富驰医药化工股份有限公司 | 2020-10-30 | — | — | CN | claimed |
| EP-2010294-B1 | ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2015-12-02 | — | — | EP | claimed |
| US-7906684-B2 | Antioxidants | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-03-15 | — | — | US | claimed |
| US-20090246158-A1 | ANTIOXIDANTS | MERCK PATENT GESELLSCHAFT (DE) | 2009-10-01 | — | — | US | claimed |
| EP-2010294-A1 | ANTIOXIDANTS | Merck Patent GmbH (DE) | 2009-01-07 | — | — | EP | claimed |
| WO-2007121845-A1 | ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2007-11-01 | — | — | WO | claimed |
| CN-119528780-A | Eugenol modified alkali-soluble photo-curing epoxy resin and preparation method and application thereof | 广东炎墨方案科技股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-117924666-B | High heat-resistant degradable light-cured resin containing spiro diacetal structure and preparation method thereof | 广东炎墨方案科技股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119371390-A | High-performance photo-curing solder resist ink based on biomass soyabean element and preparation method thereof | 广东炎墨方案科技股份有限公司 | 2025-01-28 | — | — | CN | disclosed |
| CN-117430505-B | Itaconic acid derived glycidyl ether photo-curing epoxy resin and preparation method and application thereof | 广东炎墨方案科技股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-119019443-A | Strong-effect nontoxic antibacterial antiviral nano functional material, preparation and application | 云广技术(深圳)有限公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-117843921-B | Method for preparing high-performance photosensitive solder resist ink based on diamine chain extension modified bisphenol epoxy resin | 广东炎墨方案科技有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-116768728-B | Method for preparing high-performance photosensitive solder resist ink from naphthalene type chain extension modified epoxy resin | 广东炎墨方案科技有限公司 | 2024-08-23 | — | — | CN | disclosed |
| EP-1165486-A1 | IONIC LIQUIDS | UNIVERSITY OF LEICESTER (GB) | 2002-01-02 | — | — | EP | disclosed |
| WO-2000056700-A1 | IONIC LIQUIDS | UNIVERSITY OF LEICESTER (GB) | 2000-09-28 | — | — | WO | disclosed |
| US-5880301-A | CATALYSTS FOR PREPARATION OF OPTICALLY ACTIVE BETA-HYDROXYKETONES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1999-03-09 | — | — | US | disclosed |
| EP-0811629-A1 | OPTICALLY ACTIVE BIDENTATE PHOSPHINE LIGAND/PALLADIUM COMPLEX | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1997-12-10 | — | — | EP | disclosed |
| WO-1993001158-A1 | METHOD FOR THE PREPARATION OF ARYLKETOAMINES | HOECHST CELANESE CORPORATION (US) | 1993-01-21 | — | — | WO | disclosed |
| EP-0297435-A2 | Aminopropanol derivatives of 3-(3'-hydroxyphenyl)-1-propanone, process for their preparation and medicines containing these compounds | Helopharm W. Petrik GmbH & Co.KG. (DE) | 1989-01-04 | — | — | EP | disclosed |
| EP-0296265-A1 | Aminopropanol derivatives of 3-(3-hydroxyphenyl)-1-propanone, process for their preparation and medicines containing these compounds | Helopharm W. Petrik GmbH & Co.KG. (DE) | 1988-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090246158-A1 | ANTIOXIDANTS | LPO, GPX1, GPX4 | TSHR 3664/4885SMN1; SMN2 1726/4885NPC1 680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.